SMTL ID : 5hi5.1

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-2-2-2-1-mer

Ligands

1 x 63Q: (4S,20R)-7-chloro-N-methyl-4-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-3,18-dioxo-2,19-diazatetracyclo[20.2.2.1~6,10~.1~11,15~]octacosa-1(24),6(28),7,9,11(27),12,14,22,25-nonaene-20-carboxamide(Non-covalent)

63Q.1: 21 residues within 4Å: Chain A: P.63, I.66, Q.94, E.95, I.96, L.97, V.98, K.114 Chain B: N.36, P.37, Y.62, P.63, V.65, I.66, W.67, E.95, I.96, L.97, V.98, L.99, L.112 11 PLIP interactions: 4 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:I.96, A:L.97, B:Y.62, B:Y.62, B:P.63, B:I.96 Hydrogen bonds: A:L.97, A:L.97, B:W.67, B:L.97, B:L.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, S. et al., Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep (2016)

Release Date

2016-08-31

Peptides

Interleukin-17A: AB
CAT-2000 FAB heavy chain: CE
CAT-2000 light chain: DG
synthetic IL-17A inhibitor: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

E
H

D
D

G
L

F
I

Interleukin-17A

CAT-2000 FAB heavy chain

CAT-2000 light chain

synthetic IL-17A inhibitor

Related Entries With Identical Sequence